VALENS GROWORKS

Marijuana Legalisation 2.0 – How Edibles and Extracts will Upend the Market

In October 2019, Canada will experience its second wave of marijuana legalisation In the past we've discussed how poorly implemented the legalisation of recreational cannabis has b...

Grow On… Valens Reports Q2 Results – Revenue Up 296%

Kelowna, B.C., July 15, 2019 – Valens GroWorks Corp. (TSXV: VGW) (OTC: VGWCF) (the "Company" or "Valens"), a vertically integrated provider of industry leading extraction produc...

Meet The Cannabis Extraction Powerhouses – MediPharm Labs & THC Global

MediPharm Labs is quickly becoming the global extraction powerhouse, but Australia has a potential contender waiting in the wings.We have often written about the extraction market ...

Valens Ballparks $17 Million Revenue For Q3

Kelowna, B.C., September 10th, 2019 – Valens GroWorks Corp. (TSXV: VGW) (OTCQX: VGWCF) (the "Company" or "Valens"), a vertically integrated provider of industry-leading extractio...

Valens Becomes Cannabis Oil Supplier for Shoppers Online Retail

Kelowna, B.C., September 16, 2019 – Valens GroWorks Corp. (TSXV: VGW) (OTC: VGWCF) (the "Company" or "Valens"), a vertically integrated provider of industry leading extraction pr...

Valens Wins Award for Top Extraction Company of the Year

Valens takes home award for being the Top Extraction Company of the Year at the Canadian Cannabis Awards The Valens team is pleased to announce Valens attended the 6th Annual Canad...

Valens Expands Operations in Toronto With it's New Acquisition of a Leading Hard Cider Manufacturer

Valens acquires Pommies Cider Co, a leading Ontario-based beverage company Valens GroWorks Corp, a vertically integrated provider of industry leading extraction products and servic...

Valens Brings Leading Cannabis Infusion Technology to International Markets

Valens expands exclusive licence for SōRSE cannabis emulsion technology to include Europe, Australia and Mexico in addition to CanadaValens GroWorks Corp, a cannabinoid-based prod...

Valens Announces Revenue Guidance for Fourth Quarter 2019

Valens announces Q4 2019 revenue guidance of $27 million – $30 million, a near doubling of Q3, 2019 reported revenue.Valens GroWorks Corp, a cannabinoid-based product company wit...

Racking Up Wins – Althea Enters the German Market, Reaches 3,000 Patients and Secures UK License

CV Sciences announces a new distribution partnership, THC Global secures a Manufacture License, MGC Pharma receives its first grant payment from the Australian Government, and more...